US Stock MarketDetailed Quotes

INDP Indaptus Therapeutics

Watchlist
  • 0.950
  • 0.000-0.02%
Close Jan 13 16:00 ET
11.41MMarket Cap-0.56P/E (TTM)

About Indaptus Therapeutics Company

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Company Profile

SymbolINDP
Company NameIndaptus Therapeutics
Listing DateAug 4, 2015
CEOMr. Jeffrey A. Meckler
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address3 Columbus Circle,15th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-646-427-2727

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey A. Meckler
  • Chief Executive Officer and Director
  • 1.00M
  • Nir Sassi
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Walt A. Linscott, Esq.
  • Chief Operating Officer
  • 770.04K
  • Roger J. Waltzman, M.D.
  • Chief Medical Officer
  • --
  • Dr. Michael J. Newman, PhD
  • Chief Scientific Officer and Director
  • 718.04K
  • Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
  • Chairman of the Board
  • 195.66K
  • Anthony J. Maddaluna
  • Independent Director
  • 87.14K
  • William Bradley Hayes
  • Independent Director
  • 90.03K
  • Dr. Mark J. Gilbert, M.D.
  • Independent Director
  • 132.14K
  • Hila Karah
  • Independent Director
  • 83.17K
  • Dr. Robert E. Martell, M.D.,PhD
  • Independent Director
  • 79.67K
Trending US Stocks
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.